Preliminary safety and efficacy of IPI-145, a potent inhibitor of phosphoinositide-3-kinase-δ,γ in patients with relapsed/refractory lymphoma Meeting Abstract


Authors: Horwitz, S. M.; Flinn, I.; Patel, M. R.; Younes, A.; Foss, F. M.; Oki, Y.; Sweeney, J.; Allen, K.; Dunbar, J.; Kelly, P. F.; Kahl, B. S.
Abstract Title: Preliminary safety and efficacy of IPI-145, a potent inhibitor of phosphoinositide-3-kinase-δ,γ in patients with relapsed/refractory lymphoma
Meeting Title: 49th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 31
Issue: 15 Suppl.
Meeting Dates: 2013 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2013-05-20
Language: English
ACCESSION: WOS:000335419602614
PROVIDER: wos
Notes: Meeting Abstract: 8518 -- Source: Wos
MSK Authors
  1. Steven M Horwitz
    351 Horwitz